SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-22-013846
Filing Date
2022-04-07
Accepted
2022-04-07 16:14:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A rgnx-defa14a_20220603.htm DEFA14A 12679
2 GRAPHIC grr4gvc5pyvl000002.jpg GRAPHIC 344647
3 GRAPHIC grr4gvc5pyvl000001.jpg GRAPHIC 521868
  Complete submission text file 0001564590-22-013846.txt   1206815
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37553 | Film No.: 22814021
SIC: 2836 Biological Products, (No Diagnostic Substances)